Fundraising FoxNf2Tx
Cambridge, US · 1 known investors
Find your way into Nf2Tx
Sign up to see every warm intro you have to Nf2Tx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nf2Tx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
NF2 Therapeutics (NF2Tx) is a biotech company developing therapies for neurofibromatosis 2 related schwannomatosis (NF2) and related disorders, including an antibody drug conjugate targeting meningiomas and an AAV-based gene therapy for vestibular schwannomas. It works with patients, physicians, and researchers to develop treatments for these rare genetic disorders.
Founders & leadership
MW
Michael WoottonCo-Founder & CEO
MD
Mark de SouzaCo-Founder
SP
Scott PlotkinCo-Founder
Board
MG
Marco Giovannini
Investors · 1
Frequently asked questions
- What does Nf2Tx do?
- NF2 Therapeutics (NF2Tx) is a biotech company developing therapies for neurofibromatosis 2 related schwannomatosis (NF2) and related disorders, including an antibody drug conjugate targeting meningiomas and an AAV-based gene therapy for vestibular schwannomas. It works with patients, physicians, and researchers to develop treatments for these rare genetic disorders.
- Who founded Nf2Tx?
- Nf2Tx was founded by Michael Wootton, Mark de Souza, Scott Plotkin.
- Who are Nf2Tx's investors?
- Nf2Tx's investors include Beacon Angels.
- Where is Nf2Tx headquartered?
- Nf2Tx is headquartered in Cambridge, US.